Submit your email to push it up the queue
Baxter Healthcare Limited, a prominent player in the global healthcare industry, is headquartered in the United Kingdom. Founded in 1931, the company has established itself as a leader in medical products and services, focusing on areas such as renal care, medication delivery, and surgical products. With a strong presence in Europe, North America, and Asia, Baxter is dedicated to improving patient outcomes through innovative solutions. The company’s core offerings include advanced dialysis equipment, intravenous therapies, and surgical products, all designed to enhance patient safety and efficiency. Baxter's commitment to quality and innovation has earned it a significant market position, recognised for its contributions to healthcare advancements. With a rich history of milestones, Baxter continues to shape the future of healthcare, making a meaningful impact on patients and healthcare providers alike.
How does Baxter Healthcare Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Baxter Healthcare Limited's score of 40 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Baxter Healthcare Limited reported total carbon emissions of approximately 5,091,000,000 kg CO2e. This figure includes about 313,000,000 kg CO2e from Scope 1 emissions and approximately 4,491,000,000 kg CO2e from Scope 3 emissions. The previous year, 2022, saw total emissions of about 5,259,000,000 kg CO2e, with Scope 1 emissions at around 338,000,000 kg CO2e and Scope 3 emissions at approximately 4,661,000,000 kg CO2e. In 2021, the company reported total emissions of about 57,469,000 kg CO2e, with Scope 1 emissions of approximately 21,131,000 kg CO2e and Scope 3 emissions of about 36,751,000 kg CO2e. Baxter Healthcare Limited does not currently have specific reduction targets or initiatives disclosed, nor does it participate in the Science Based Targets initiative (SBTi). The emissions data is cascaded from its parent company, Baxter International Inc., reflecting the company's commitment to transparency in its environmental impact. Overall, Baxter Healthcare Limited's emissions profile highlights the significant contribution of Scope 3 emissions, which represent the majority of its carbon footprint. The company continues to navigate its climate commitments within the healthcare sector, focusing on improving sustainability practices.
Access structured emissions data, company-specific emission factors, and source documents
2021 | 2022 | 2023 | |
---|---|---|---|
Scope 1 | 21,131,000 | 000,000,000 | 000,000,000 |
Scope 2 | - | - | - |
Scope 3 | 36,751,000 | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Baxter Healthcare Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.